Mã chứng khoánMRNX
Loại tài sảnEquity
Nhà quản lý quỹDefiance
Cư trúUS
Tỷ lệ chi phí1.34%
Được thành lập vào2026-02-03
Chỉ số theo dõi--
MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.